(Q44711407)

English

3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

John K Buolamwini

3

object named as

John K Buolamwini

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Haregewein Assefa

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Shantaram Kamath

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Journal of Computer - Aided Molecular Design

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

475-493

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The EGF receptor family as targets for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rational design of potent and selective EGFR tyrosine kinase inhibitors as anticancer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal gro

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of a genetic algorithm for flexible docking

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin,

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ErbB receptor family: a therapeutic target for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5D-QSAR: the key for simulating induced fit?

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MOPAC: a semiempirical molecular orbital program

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ZD1839 ('Iressa') as an anticancer agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of new hydrogen-bond descriptors and their application to comparative molecular field analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/14703120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/B:JCAM.0000004622.13865.4F

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

DBLP publication ID

journals/jcamd/AssefaKB03

1 reference

DBLP Dataset 2021-01-02

28 January 2021

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44711407&oldid=2206862829"